No paralogue variants have been mapped to residue 530 for RYR1.
RYR1 | AHFAEFAGEEAAESWKEIVNLLYELLASLI>R<GNRSNCALFSTNLDWLVSKLDRLEASSGIL | 560 |
RYR2 | AHFADVAGREAGESWKSILNSLYELLAALI>R<GNRKNCAQFSGSLDWLISRLERLEASSGIL | 572 |
RYR3 | AHFAGIAREESGMAWKEILNLLYKLLAALI>R<GNRNNCAQFSNNLDWLISKLDRLESSSGIL | 559 |
cons | > < |
Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
---|---|---|---|---|---|
p.R530H | c.1589G>A | Other Myopathy | rs111888148 | SIFT: Polyphen: | |
Reports | Other Myopathy | Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mutat. 2006 27(10):977-89. 16917943 | |||
Other Myopathy | Functional characterization of ryanodine receptor (RYR1) sequence variants using a metabolic assay in immortalized B-lymphocytes. Hum Mutat. 2009 30(4):E575-90. 19191333 | ||||
Unknown | Actionable exomic incidental findings in 6503 participants: challenges of variant classification. Genome Res. 2015 25(3):305-15. doi: 10.1101/gr.183483.114. 25637381 | ||||
p.R530C | c.1588C>T | Putative Benign | SIFT: Polyphen: | ||
p.Arg530Leu | c.1589G>T | Unknown | SIFT: Polyphen: |